Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Chromatography Advances Drug Discovery
High-Resolution Chromatography Addresses Niche Markets and Creates Turn-Key Solutions
- Companies are addressing requests for higher throughput with higher resolution in chromatography by developing more sophisticated platforms. In addition, many are introducing nanoscale instruments for protein separation and addressing niche markets like Mab separation, while others are developing turn-key solutions with advanced software capabilities. GE Healthcare (www.gehealthcare.com) recently ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.